|
KRAS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.89240000000513E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.6456000000058E-05 |
| Normal-vs-Stage2 |
3.003400E-03 |
| Normal-vs-Stage3 |
4.437000E-04 |
| Normal-vs-Stage4 |
1.550840E-04 |
| Stage1-vs-Stage2 |
9.875800E-01 |
| Stage1-vs-Stage3 |
7.901600E-01 |
| Stage1-vs-Stage4 |
2.889200E-01 |
| Stage2-vs-Stage3 |
8.570000E-01 |
| Stage2-vs-Stage4 |
4.376200E-01 |
| Stage3-vs-Stage4 |
4.777600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.31829999999867E-05 |
| Normal-vs-AfricanAmerican |
1.696430E-02 |
| Normal-vs-Asian |
3.798600E-04 |
| Caucasian-vs-AfricanAmerican |
6.953800E-01 |
| Caucasian-vs-Asian |
6.898800E-01 |
| AfricanAmerican-vs-Asian |
5.132800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.37479999999746E-05 |
| Normal-vs-Female |
8.26290000000007E-05 |
| Male-vs-Female |
5.948800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.644300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.51050999999125E-05 |
| Normal-vs-Age(61-80Yrs) |
7.980300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.477000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.419000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.622400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.627000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.202400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.386000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.410600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.319000E-01 |
| Classical-VS-Follicular |
2.175000E-01 |
| Classical-VS-Other |
8.820100E-02 |
| Classical-VS-Normal |
5.026800E-04 |
| Tall-VS-Follicular |
6.889600E-01 |
| Tall-VS-Other |
1.412000E-01 |
| Tall-VS-Normal |
6.997200E-03 |
| Follicular-VS-Other |
2.379400E-01 |
| Follicular-VS-Normal |
2.369200E-04 |
| Other-VS-Normal |
1.677960E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.08879999999967E-05 |
| Normal-vs-N1 |
1.99281999999634E-05 |
| N0-vs-N1 |
4.242400E-01 |
|
|
